ARTICLE | Distillery Therapeutics
Cancer
April 4, 2017 10:08 PM UTC
Patient sample, cell culture and mouse studies suggest inhibiting ALKBH5 could help treat glioblastoma multiforme (GBM). In patients, high tumor levels of ALKBH5 correlated with poor survival. In thre...
BCIQ Company Profiles
BCIQ Target Profiles